ALI FARAZ (Chief Executive Officer) received a stock award from TENAYA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/12/2026ACC: 0001193125-26-389563
DirectorOfficer· Chief Executive Officer
Since Jul 2021
+854.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
854.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+122K
Price / share
—
Trade value
—
% of position
29.2%
9/10/2026
417.78K→539.78K
Total
Net shares
+122K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/10/2026 | A · Award | +122K | — | — | 29.2% | 417.78K | 539.78K |
| Total | +122K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to buy)
Direct
Converts to
Common Stock
732.50K shares
Shares
+732.50K
Strike price
0.6488
Held after
732.50K
Exercisable
—
9/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Direct | Common Stock732.50K shares | 9/10/2026 | A · Award | +732.50K | 0.6488 | — | 732.50K |